[ad_1]
Halliburton Co.’s stock fell 2% early Friday, after the oil services provider posted second-quarter earnings showing profit matching consensus but revenue falling short.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...